Literature DB >> 1719177

Correlates of concern in parents of high-risk infants at age five.

A M Jensen1, D C Harper.   

Abstract

Parents whose children have experienced a high-risk birth may be in double jeopardy due to the biomedical effects of the birth trauma as well as parent perceptions and feelings regarding medical vulnerability and the subsequent impact on caregiving. The present study determined whether the developmental, social, and medical concerns reported by 223 parents of high-risk infants at age 5 were congruent with the child's medical history and developmental performance at age 5. Results indicated that parents with the highest levels of developmental, social, and medical concerns had children with lower birth weights who were born earlier and spent longer periods of time in the hospital at birth. These children also had lower outcomes on the cognitive ability measures at age 5, and were more likely to demonstrate potential behavior problems. Present findings suggest the degree of concern reported by parents of high-risk infants is congruent with the birth history and the developmental status of their child.

Entities:  

Mesh:

Year:  1991        PMID: 1719177     DOI: 10.1093/jpepsy/16.4.429

Source DB:  PubMed          Journal:  J Pediatr Psychol        ISSN: 0146-8693


  3 in total

1.  The differences in health concerns between mothers and health care professionals in a preventive community set up.

Authors:  E Tirosh; Y Mansour; M Jaffe; A Cohen
Journal:  Eur J Epidemiol       Date:  1998-04       Impact factor: 8.082

2.  Parental concerns about their premature infants' health after discharge from the neonatal intensive care unit: a questionnaire survey for anticipated guidance in a neonatal follow-up clinic.

Authors:  Ji-Yun Cho; Juyoung Lee; Young Ah Youn; Soon Ju Kim; So Young Kim; In Kyung Sung
Journal:  Korean J Pediatr       Date:  2012-08-23

3.  Rethinking stress in parents of preterm infants: a meta-analysis.

Authors:  Renske Schappin; Lex Wijnroks; Monica M A T Uniken Venema; Marian J Jongmans
Journal:  PLoS One       Date:  2013-02-06       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.